Clinical Trial Update: Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bedaquiline as enhanced post-exposure prophylaxis for leprosy has completed. Results were posted in August 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy

Drugs mentioned

• bedaquiline (bedaquiline)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Leprosy | Phase 2 | Status: COMPLETED | Results posted: 2024-08-28